Table 1.

Age stratified clinical manifestations of patients with COVID-19 in Bangladesh.

Variables	Age group in years (%)								P value
	0–9	10–19	20–29	30–39	40–49	50–59	60–69	>70
Total number, N	5	51	319	205	161	139	63	23	.027
Symptoms	4 (80%)	39 (76.5%)	239 (74.9%)	164 (80%)	127 (78.9%)	119 (85.6%)	52 (82.5%)	21 (91.3%)	.014
Fever
Dry Cough	4 (80%)	23 (45.1%)	153 (48%)	126 (61.5%)	89 (55.3%)	88 (63.3%)	39 (61.9%)	12 (52.2%)	.043
Loss of taste or smell	1 (20%)	28 (54.9%)	162 (50.8%)	106 (51.7%)	85 (52.8%)	72 (51.8%)	26 (41.3%)	9 (39.1%)	.541
Fatigue	2 (40%)	24 (47.1%)	155 (48.6%)	99 (48.3%)	69 (42.9%)	68 (48.9%)	32 (50.8%)	10 (43.5%)	.674
Body aches	0 (0%)	26 (51%)	133 (41.7%)	80 (39%)	73 (45.3%)	64 (46%)	27 (42.9%)	14 (60.9%)	.034
Sore throat	1 (20%)	20 (39.2%)	116 (36.4%)	83 (40.5%)	65 (40.4%)	68 (48.9%)	25 (39.7%)	6 (26.1%)	.061
Shortness of breath	0 (0%)	14 (27.5%)	85 (26.6%)	58 (28.3%)	55 (34.2%)	59 (42.4%)	37 (58.7%)	16 (69.6%)	.011
Chest pain or pressure	0 (0%)	10 (19.6%)	43 (13.5%)	29 (14.1%)	27 (16.8%)	36 (25.9%)	16 (25.4%)	9 (39.1%)	.042
Diarrhea	0 (0%)	6 (11.8%)	52 (16.3%)	34 (16.6%)	31 (19.3%)	25 (18%)	12 (19%)	6 (26.1%)	.013
Loss of speech or movement	1 (20%)	5 (9.8%)	31 (9.7%)	12 (5.9%)	13 (8.1%)	18 (12.9%)	11 (17.5%)	6 (26.1%)	.027
Inflammation of the eye	0 (0%)	4 (7.8%)	16 (5%)	5 (2.4%)	3 (1.9%)	6 (4.3%)	5 (7.9%)	2 (8.7%)	.062
Rash	0 (0%)	5 (9.8%)	8 (2.5%)	6 (2.9%)	5 (3.1%)	7 (5%)	3 (4.8%)	6 (26.1%)	.041
Runny nose/Fluxes	0 (0%)	1 (2%)	1 (0.3%)	2 (1%)	0 (0%)	1 (0.7%)	0 (0%)	1 (4.3%)	.083
Vomiting	0 (0%)	0 (0%)	1 (0.3%)	3 (1.5%)	0 (0%)	1 (0.7%)	0 (0%)	0 (0%)	.493
Others	0 (0%)	1 (2%)	2 (0.6%)	2 (1%)	3 (1.9%)	1 (0.7%)	2 (3.2%)	0 (0%)	.792
No Symptoms	0 (0%)	1 (2%)	4 (1.3%)	3 (1.5%)	0 (0%)	6 (4.3%)	1 (1.6%)	0 (0%)	.137